EUVIMEDEUVIMED entdecken
Crossref

Synthesis and Biological Activity for 1,3,4‐Thiadiazole–2‐Iminothiazolidin‐4‐Ones: Antidiabetic and Anti‐Alzheimer Activity

Vu Ngoc Toan, Nguyen Dinh Thanh iD, Nguyen Minh Tri

ChemMedChem · 2025

DOI: 10.1002/cmdc.202500620 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2025. Verfasst von Vu Ngoc Toan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Materials, Biology and Environment, Military Institute of Science and Technology, 17 Hoang Sam, Nghia Do, 11300, Ha Noi, Viet Nam. Hauptthemen laut MEDLINE: Alzheimer Disease, Hypoglycemic Agents, Thiadiazoles, Thiazoles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 75 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of 2‐iminothiazolidin‐4‐one–1,3,4‐thiazole hybrids 7a–l are synthesized and screened for their inhibitory activities against responsible enzymes in type 2 diabetes mellitus (T2DM) and Alzheimer's diseases. Among the compounds with potential inhibitory activity, several 2‐iminothiazolidin‐4‐ones exhibit the strongest inhibitory activity against the screened enzymes, including 7c (IC 50 = 6.12 ± 0.11 µM, for α‐amylase), 7e (IC 50 = 6.78 ± 0.15 µM, for α‐glucosidase), 7k (IC 50 = 1.82 ± 0.04 µM, for DPP‐4), 7f (IC 50 = 2.21 ± 0.02 µM, for PTP1B), 7h (IC 50 = 0.06 ± 0.01 nM, for AChE), 7j (IC 50 = 0.03 ± 0.01 nM, for BChE, and IC 50 = 0.32 ± 0.01 nM, for MAO‐A), and 7l (IC 50 = 0.02 ± 0.01 nM, for MAO‐B). Compound 7j exhibits the strongest inhibitory activity for both BChE and MAO‐A. Compounds with short‐chain alkyl groups (2–4 carbon atoms) have the strongest inhibitory activity against the enzymes responsible in T2DM, with the exception of 7k (with 6‐carbon atom chain), whereas the long‐chain alkyl groups (with 5–7 carbon atom chains) have the strongest inhibitory activity against the enzymes responsible in Alzheimer's disease. These compounds also exhibit the high antiglycation and antioxidant activity in DPPH and ABTS •+ scavenging assays. They are noncytotoxic for WI‐38 cell line with IC 50 > 76 μM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHypoglycemic AgentsThiadiazolesThiazolesEnzyme InhibitorsHumansStructure-Activity RelationshipDiabetes Mellitus, Type 2alpha-GlucosidasesMolecular Structurealpha-AmylasesDose-Response Relationship, DrugAcetylcholinesteraseDipeptidyl Peptidase 4ButyrylcholinesteraseCholinesterase InhibitorsProtein Tyrosine Phosphatase, Non-Receptor Type 1Antioxidants

Stichwörter der Autor:innen

1,2,3‐thiadiazole2‐iminothiazolidin‐4‐oneantidiabeticanti‐Alzheimerhybrid compounds

Substanzen

Hypoglycemic Agentsalpha-GlucosidasesThiadiazolesalpha-Amylases1,3,4-thiadiazoleAcetylcholinesteraseDipeptidyl Peptidase 4ButyrylcholinesteraseCholinesterase InhibitorsThiazoles

Autor:innen und Institutionen

  • Institute of Materials, Biology and Environment, Military Institute of Science and Technology, 17 Hoang Sam, Nghia Do, 11300, Ha Noi, Viet Nam.
  • Department of Chemistry, VNU University of Science, 19 Le Thanh Tong, Cua Nam, 11000, Ha Noi, Viet Nam.

ORCID-Profile: Nguyen Dinh Thanh

Zitieren

APA

Toan, V. N., Thanh, N. D., & Tri, N. M. (2025). Synthesis and Biological Activity for 1,3,4‐Thiadiazole–2‐Iminothiazolidin‐4‐Ones: Antidiabetic and Anti‐Alzheimer Activity. ChemMedChem. https://doi.org/10.1002/cmdc.202500620

Vancouver

Toan VN, Thanh ND, Tri NM. Synthesis and Biological Activity for 1,3,4‐Thiadiazole–2‐Iminothiazolidin‐4‐Ones: Antidiabetic and Anti‐Alzheimer Activity. ChemMedChem. 2025. doi:10.1002/cmdc.202500620

BibTeX
@article{Toan2025,
  author = {Toan, Vu Ngoc and Thanh, Nguyen Dinh and Tri, Nguyen Minh},
  title = {Synthesis and Biological Activity for 1,3,4‐Thiadiazole–2‐Iminothiazolidin‐4‐Ones: Antidiabetic and Anti‐Alzheimer Activity},
  journal = {ChemMedChem},
  year = {2025},
  doi = {10.1002/cmdc.202500620}
}
Kostenlos starten →